HK Stock Market Move | BOE VARITRONIX (00710) is now up more than 4%. The strong demand for automotive displays, with the production capacity utilization rate of the Chengdu factory expected to reach 70% by the end of the year.
BOE Varitronix Limited (00710) is currently up more than 4%, as of the deadline for submission, it is up 3.68%, trading at 6.48 Hong Kong dollars, with a turnover of 20.54 million Hong Kong dollars.
BOE VARITRONIX (00710) is now up more than 4%, as of the time of writing, it is up 3.68% at HKD 6.48, with a trading volume of HKD 20.54 million.
Citibank has released a research report stating that it has raised BOE VARITRONIX's target price from HKD 5.6 to HKD 8.5. The company's strategy of focusing on the top ten auto original equipment manufacturers in the mainland in the second half of last year and in 2025 will continue to drive market share growth. Additionally, gross profit recovery is expected, as the stable increase in production at the Chengdu factory and the reduction in inventory depreciation impacts are expected to improve gross profit margin.
The bank stated that looking ahead to 2025, with the acceleration of the trend towards intelligent cockpits, it is expected that demand for automotive displays will remain strong. The bank forecasts that the utilization rate of the Chengdu factory's production capacity could reach 70% to 80% by the end of 2025, supporting the improvement of financial performance. The bank maintains a "buy" rating.
Related Articles
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.

Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.
Crown Advanced Material (688560.SH) terminates investment agreement with CECEP Solar Energy for backsheet and functional film production base project.
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


